查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1489302

全球类器官市场：2033 年的机会与策略

Organoids Global Market Opportunities And Strategies To 2033
出版日期: | 出版商: The Business Research Company | 英文 309 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2018年全球类器官市场价值为13.0605亿美元，到2023年复合年增长率将超过20.00%。

对个人化医疗的需求不断增加

对个人化医疗的需求不断增长推动了类器官市场的成长。个人化医疗，也称为精准医疗或个人化医疗，是一种医疗方法，旨在提供适合每个患者特征的治疗和介入措施。类器官复製个别患者特征的能力已成为根据特定遗传特征和疾病特征量身定制治疗的重要工具。需求的激增提高了类器官在药物测试、疾病建模和精准医学应用中的重要性和采用率。例如，2022 年 10 月，代表科学家、患者和医疗保健提供者的美国组织个人化医疗联盟宣布，多种类型的癌症、遗传性罕见疾病以及我们估计有超过 75,000 种基因检测产品和市场上有300多种针对慢性病和感染疾病患者的个人化药物。此外，根据倡导个人化医疗的美国个人化医疗联盟（PMC）预计，预计2022年美国食品药物管理局新药认证中个人化药品将占到34%，其中个人化药品占比更高；超过25%的核准。因此，个人化医疗需求的不断增长支撑了历史时期类器官市场的成长。

目录

第一章执行摘要

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章市场特点

  • 一般市场定义
  • 概述
  • 类器官市场定义与细分
  • 市场区隔：按产品
    • 肝臟类器官
    • 结肠类器官
    • 肠类器官
    • 其他的
  • 市场区隔：按应用
    • 发育生物学
    • 感染疾病病理学
    • 再生医学
    • 测试药物毒性和功效
    • 药物发现与个人化医疗
    • 其他的
  • 市场区隔：依最终用途产业
    • 医院和诊断中心
    • 生物製药公司
    • 学术机构/研究机构
    • 受託研究机构
  • 市场区隔：依原产地
    • 多功能能干细胞
    • 器官特异性成体干细胞

第七章 主要市场趋势

  • 扩展解决方案，重点关註生物製药研究的类器官解决方案
  • 创建专门的 3D 细胞模型的生命科学研究进展
  • 开发基于心臟类器官的套件以改善心臟安全测试
  • 策略伙伴关係与协作，推动下一代类器官技术
  • 专注于高通量应用的客自订类器官生产线服务
  • 更多采用 3D 细胞培养技术来加速类器官和细胞收穫

第 8 章类器官市场：宏观经济情景

  • COVID-19 的影响：类器官市场
  • 乌克兰战争的影响：类器官市场
  • 高通膨的影响：类器官市场

第九章世界市场规模与成长

  • 市场规模
  • 2018-2023 年市场成长表现
    • 2018-2023年市场驱动因素
    • 2018-2023年市场限制因素
  • 市场成长预测，2023-2028，2033F
    • 2023-2028年市场驱动因素
    • 2023-2028年市场限制因素

第十章全球类器官市场：细分

  • 全球类器官市场：按产品、性能和预测，2018-2023、2028F、2033F
  • 全球类器官市场：按应用、性能和预测，2018-2023、2028F、2033F
  • 全球类器官市场：最终用途产业的实际状况与预测，2018-2023、2028F、2033F
  • 全球类器官市场：按来源、性能和预测，2018-2023、2028F、2033F

第十一章类器官市场：区域/国家分析

  • 全球类器官市场：按地区、绩效及预测，2018-2023、2028F、2033F
  • 全球类器官市场：依国家、绩效及预测，2018-2023、2028F、2033F

第十二章亚太市场

第十三章西欧市场

第十四章 东欧市场

第十五章 北美市场

第十六章 南美洲市场

第十七章 中东市场

第十八章 非洲市场

第十九章 竞争格局及公司概况

  • 公司简介
  • Thermo Fisher Scientific Inc
  • Carl Zeiss AG
  • Corning Incorporated
  • Lonza Group Ltd
  • STEMCELL Technologies Inc

第20章 竞争基准化分析

第 21 章竞争对手仪表板

第二十二章 重大併购

  • Axosim Acquired The Microbrain-Associated Assets Of Vyant Bio's Stemonix Subsidiary
  • Bruker Corporation Acquired Acquifer Imaging
  • Molecular Devices Acquired Cellesce
  • Crown Bioscience International Acquired OcellO

第23章机会与策略

  • 全球类器官市场：提供新机会的国家
  • 全球类器官市场：提供新机会的细分市场
  • 全球类器官市场：成长策略

第24章类器官市场：结论与建议

  • 结论
  • 推荐

第25章附录

简介目录
Product Code: o&s1233

Organoids are three-dimensional cell cultures that mimic the structural and functional characteristics of real organs. These miniature, simplified versions of organs are grown from stem cells in a laboratory environment to replicate some of the complex biological structures and processes of their full-sized counterparts.

The organoids market consists of sales, by entities (organizations, sole traders and partnerships), of organoids products that are a revolutionary tool in modern biomedical research and medicine, enabling scientists and doctors to study human development, disease progression and drug responses in a controlled and replicable way.

The global organoids market was valued at $1,306.05 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 20.00%.

Increase In Demand For Personalized Medicine

An increase in demand for personalized medicine propelled the growth of the organoids market. Personalized medicine, also known as precision medicine or individualized medicine, is an approach to medical care that aims to tailor treatments and interventions to the specific characteristics of each patient. Organoids, with their ability to replicate individual patient characteristics, have become indispensable tools in tailoring medical treatments to specific genetic profiles and disease characteristics. This demand surge has elevated the significance and adoption of organoids in drug testing, disease modeling and precision medicine applications. For instance, in October 2022, the Personalized Medicine Coalition, a US-based organization that represents scientists, patients and providers, promoting the understanding and adoption of personalized medicine to benefit patients and the healthcare system), estimated that more than 75,000 genetic testing products and 300 personalized medicines are on the market for people with multiple types of cancers, genetic rare diseases and a range of chronic and infectious diseases. Additionally, according to the Personalized Medicine Coalition (PMC), a US-based company that advocates for personalized medicine, personalized medicines were estimated to account for 34% of new drug approvals by the US Food and Drug Administration in 2022 and have accounted for at least 25% of approvals in each of the previous eight years. Therefore, the increase in demand for personalized medicine supported the growth of the organoids market during the historic period.

Advancements In Life Science Research For The Production Of Specialized 3D Cell Models

Companies are focusing on advancements in life science research for the production of specialized 3D organoids, representing a substantial stride in biomedical advancement. These pioneering advancements entail crafting organoids that closely emulate the structural and functional intricacies of human organs, granting researchers an unparalleled understanding of disease mechanisms and drug reactions. For example, in February 2024, Cell Microsystems, a US-based biotechnology company that provides advanced tools for cell biology, announced a strategic partnership with OMNI Life Science (OLS), a Germany-based cell biology company. This collaboration endeavors to launch three groundbreaking products-CERO, CASY and TIGR-into the US and Canadian markets, advancing life science research in North America. The CERO 3D, a pioneering instrument, fosters an ideal cell culture environment for producing specialized 3D cell models, such as stem cells, spheroids, organoids and tissues.

The global organoids market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 17.50% of the total market in 2022.

Organoids Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for organoids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application, by end-use industries and by source.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the organoids market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by application, by end-use industries and by source in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Competitive Benchmarking -Briefs on the financials comparison between major players in the market.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for organoids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Hepatic Organoids; Colorectal Organoids; Intestinal Organoids; Other Organoids
  • 2) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
  • 3) By End-Use Industries: Hospitals And Diagnostic Centers; Biopharmaceutical Companies; Academics And Research Institutes; Contract Research Organizations
  • 4) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Carl Zeiss AG; Corning Incorporated; Lonza Group Ltd.; STEMCELL Technologies Inc.
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Organoids - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Organoids Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Hepatic Organoids
    • 6.4.2 Colorectal Organoids
    • 6.4.3 Intestinal Organoids
    • 6.4.4 Other Organoids
  • 6.5 Market Segmentation By Application
    • 6.5.1 Developmental Biology
    • 6.5.2 Disease Pathology Of Infectious Disease
    • 6.5.3 Regenerative Medicine
    • 6.5.4 Drug Toxicity And Efficacy Testing
    • 6.5.5 Drug Discovery And Personalized Medicine
    • 6.5.6 Other Applications
  • 6.6 Market Segmentation by End-Use Industries
    • 6.6.1 Hospitals And Diagnostic Centers
    • 6.6.2 Biopharmaceutical Companies
    • 6.6.3 Academics and Research Institutes
    • 6.6.4 Contract Research Organizations
  • 6.7 Market Segmentation By Source
    • 6.7.1 Pluripotent Stem Cells
    • 6.7.2 Organ-Specific Adult Stem Cells

7 Major Market Trends

  • 7.1 Focus On Organoid Solutions For Biotherapeutic Research And To Expand Solutions
  • 7.2 Advancements In Life Science Research For The Production Of Specialized 3D Cell Models
  • 7.3 Development Of Cardiac Organoids-Based Kits For Improved Cardiac Safety Testing
  • 7.4 Strategic Partnerships And Collaborations To Advance Next-Generation Organoids Technology
  • 7.5 Focus On Custom Organoid Line Services For High-Throughput Applications
  • 7.6 Rising Adoption Of 3D Cell Culture Techniques To Expedite Organoid And Cell Harvesting

8 Organoids Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Organoids Market
  • 8.2 Impact Of The War In Ukraine On The Organoids Market
  • 8.3 Impact Of High Inflation On The Organoids Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Organoids Market Segmentation

  • 10.1 Global Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Organoids Market, Segmentation By Source, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Organoids Market, Regional and Country Analysis

  • 11.1 Global Organoids Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Organoids Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Organoids Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Organoids Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Organoids Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Organoids Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Organoids Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Organoids Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Organoids Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Organoids Market, Segmentation By End-Use Industries, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Thermo Fisher Scientific Inc
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 Carl Zeiss AG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial performance
  • 19.4 Corning Incorporated
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Performance
  • 19.5 Lonza Group Ltd
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 STEMCELL Technologies Inc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Axosim Acquired The Microbrain-Associated Assets Of Vyant Bio's Stemonix Subsidiary
  • 22.2 Bruker Corporation Acquired Acquifer Imaging
  • 22.3 Molecular Devices Acquired Cellesce
  • 22.4 Crown Bioscience International Acquired OcellO

23 Opportunities And Strategies

  • 23.1 Global Organoids Market In 2028 - Countries Offering Most New Opportunities
  • 23.2 Global Organoids Market In 2028 - Segments Offering Most New Opportunities
  • 23.3 Global Organoids Market In 2028 - Growth Strategies
    • 23.3.1 Market Trend Based Strategies
    • 23.3.2 Competitor Strategies

24 Organoids Market, Conclusions And Recommendations

  • 24.1 Conclusions
  • 24.2 Recommendations
    • 24.2.1 Product
    • 24.2.2 Place
    • 24.2.3 Price
    • 24.2.4 Promotion
    • 24.2.5 People

25 Appendix

  • 25.1 Geographies Covered
  • 25.2 Market Data Sources
  • 25.3 Research Methodology
  • 25.4 Currencies
  • 25.5 The Business Research Company
  • 25.6 Copyright and Disclaimer